Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02961894Not ApplicableCompleted

Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization

Role: lead

NCT02136004Not ApplicableCompleted

The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System

Role: lead

NCT01873898Not ApplicableCompleted

Clinical Investigation of the Rex Medical -Closer™ Vascular Closure System -Reduced Time to Ambulation Trial

Role: lead

NCT00488865Not ApplicableCompleted

RexMedical- Option* Vena Cava Filter IDE Study

Role: lead

All 4 trials loaded